<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-105769</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cerebrovascular accident with haemorrhagic transformation in a patient on antiplatelet treatment subjected to surgery of a hypophyseal macroadenoma</dc:title>
<dc:description xml:lang="en">The importance of an individual assessment of each patient before surgery is emphasised, as well as a review of the antiplatelet management of the patient with a risk of thrombosis in the context of neurosurgery, and their possible postoperative complications. The case is presented of a 51 year-old woman, proposed for endoscopic endonasal transsphenoidal resection of a hypophyseal macroadenoma diagnosed in the context of a stroke suffered 10 weeks before the date of the surgery. During this time, she had been treated with antiplatelet drugs, which were withdrawn 5 days before the surgery. The surgical procedure was performed without any incidents. On the second day after the surgery, the patient had an ischaemic infarction of the left cerebellar hemisphere, with signs of hydrocephaly and a posterior haemorrhagic transformation, with brain death 5 days after the operation. There are no definitive guidelines on the use of antiplatelet drugs in the perioperative period of neurosurgery. Also, there is no agreement as regards the waiting time between a cerebrovascular event and surgery, it appears that between 4 and 12 weeks would be the most advisable. The importance of an individual assessment of each patient before surgery is emphasised, as well as a review of the antiplatelet management of the patient with a risk of thrombosis in the context of neurosurgery, and their possible postoperative complications(AU)</dc:description>
<dc:creator>Mercadal, J</dc:creator>
<dc:creator>Enseñat, J</dc:creator>
<dc:creator>Fábregas, N</dc:creator>
<dc:creator>Valero, R</dc:creator>
<dc:creator>Vendrell, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Presentamos el caso de una mujer de 51 años, propuesta para resección endoscópica endonasal transesfenoidal de macroadenoma hipofisario diagnosticado en el contexto de un ictus isquémico transitorio sufrido 10 semanas antes de la fecha de la intervención. Durante este tiempo había seguido tratamiento con antiagregantes plaquetarios, que se retiraron 5 días antes de la cirugía. La intervención se realizó sin incidencias. En el segundo día del postoperatorio, la paciente presentó un infarto isquémico del hemisferio cerebeloso izquierdo con signos de hidrocefalia y posterior transformación hemorrágica, con muerte encefálica a los 5 días de la intervención. No existen guías definitivas respecto al uso de antiagregantes en el peroperatorio neuroquirúrgico. Por otro lado, tampoco existe acuerdo respecto al tiempo a esperar entre un evento cerebrovascular y la cirugía, aunque parece que entre 4 y 12 semanas sería lo más aconsejable. Se resalta la importancia de una evaluación individual de cada paciente ante una cirugía, y se revisa el manejo del paciente antiagregado con riesgo trombótico en el contexto de neurocirugía y sus posibles complicaciones postoperatorias(AU)</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;59(8): 448-451, oct. 2012.</dc:source>
<dc:identifier>ibc-105769</dc:identifier>
<dc:title xml:lang="es">Accidente cerebrovascular con transformación hemorrágica en una paciente con tratamiento antiagregante intervenida de macroadenoma hipofisario</dc:title>
<dc:subject>^d9682^s22045</dc:subject>
<dc:subject>^d34247^s22016</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d2582^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2582^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2582^s22016</dc:subject>
<dc:subject>^d11622^s22057</dc:subject>
<dc:subject>^d14312^s22012</dc:subject>
<dc:subject>^d11344^s22057</dc:subject>
<dc:subject>^d2026^s22045</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d34247^s22057</dc:subject>
<dc:subject>^d244^s22057</dc:subject>
<dc:subject>^d11344^s22016</dc:subject>
<dc:subject>^d34247^s22012</dc:subject>
<dc:subject>^d244^s22012</dc:subject>
<dc:subject>^d7601^s22066</dc:subject>
<dc:subject>^d11344^s22009</dc:subject>
<dc:subject>^d244^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201210</dc:date>
</metadata>
</record>
</ibecs-document>
